Transarterial Chemoembolization with Epirubicin-Loaded Microspheres for Hepatocellular Carcinoma: A Prospective, Single-Arm, Multicenter, Phase 2 Study (STOPPER Trial)

ConclusionDEB-TACE using epirubicin-loaded small-sized ( ≤ 100 μm) microspheres demonstrates promising local tumor control and acceptable safety in patients with HCC.Trial RegistrationClinicaltrials.gov NCT03113955; registered April 14, 2017.Trial Registration Clinicaltrials.gov NCT03113955; registered April 14, 2017.Level of evidence2, Prospective, Non-randomized, Single-arm, study.Graphical Abstract
Source: CardioVascular and Interventional Radiology - Category: Radiology Source Type: research